The serological detection of Bovine papillomavirus’s E5 oncoprotein antibodies in horses.

Equine sarcoids (ES) are common skin tumors in horses. These tumors are caused by a virus from cows, which is unusual since it’s rare for a virus to affect a different species. Researchers examines whether horses’ immune systems try to fight this tumor.

Introduction:

• Equine sarcoids (ES) are the most common skin tumors found in horses worldwide.
• They reduce the horse’s market value, compromise their welfare, and are both challenging and costly to treat.

The Cause:

• Bovine papillomavirus (BPV) is believed to be the primary cause of ES.
• There are specific types of BPV (BPV 1, 2, and 13) that have been identified in ES.
• Interestingly, this is a unique instance where a virus affects another species, i.e., a virus from cows (bovine) affecting horses (equine).

Virus Structure:

• The BPV genome has two main coding areas:
  • The “early region E” (responsible for growth and replication): This region produces proteins named E5, E6, E7, E1, and E2.
  • The “late region” (responsible for the structure of the virus): This region produces proteins L1 and L2.

E5 Oncoprotein:

• Among the proteins produced by the virus, the E5 oncoprotein is particularly notable.
• It’s believed that E5 decreases MHC 1, a molecule that helps the immune system recognize and destroy harmful cells.
• By doing this, E5 helps the virus-infected cells evade the immune system, allowing them to grow uncontrollably and develop into ES tumors.

Research & Findings:

• The researchers developed an ELISA test targeting the E5 oncoprotein to check if horses produce antibodies against it.
• They tested 136 horses: 80 with ES and 56 without.
• The results indicated that horses do produce antibodies against the E5 oncoprotein. Notably, higher levels of these antibodies were observed mainly in horses with ES, suggesting that these horses’ immune systems were trying to combat the tumor-causing protein.

Conclusion:

The presence of antibodies against the E5 oncoprotein in horses indicates that the immune system does recognize and try to combat ES at some level. This understanding might open doors to potential treatments or preventive measures against ES in the future.